Ethical Issues in Outsourcing: The Case of Contract Medical Research and the Global Pharmaceutical Industry
Ethical Issues in Outsourcing: The Case of Contract Medical Research and the Global Pharmaceutical Industry
复制标题
DOI：
10.1007/s10551-011-0964-0
复制
发表时间：
2012-01-01
影响因子：
6.1
通讯作者：
Adobor, Henry
中科院分区：
文献类型：
--
作者：
Adobor, Henry
医学研究外包已成为全球制药业的战略要务。在竞争挑战、药物开发速度需求以及国内成本不断上升的刺激下，地球仪制药公司继续将其价值链活动的关键部分，即合同临床研究和药物测试外包给地球仪各地的赞助商，通常是新兴市场。虽然这种做法显然会产生重要的道德问题，但考虑到合同本身的定义是将责任从委托人转移到代理人，因此，道德责任和责任分配的解释并不那么清楚。这项研究提供了一个框架，探讨一些伦理问题，包括与合同医学研究相关的道德责任的归属。使用战略和道德行为理论，研究表明，在合同研究的客户和赞助商有个人和集体的责任，以确保应有的谨慎和勤勉是在临床研究的性能行使。研究为利益相关者的行动提出了一些指导方针。
The outsourcing of medical research has become a strategic imperative in the global pharmaceutical industry. Spurred by the challenges of competition, the need for speed in drug development, and increasing domestic costs, pharmaceutical companies across the globe continue to outsource critical parts of their value chain activities, namely contract clinical research and drug testing, to sponsors across the globe, typically into emerging markets. While it is clear that important ethical issues arise with this practice, unraveling moral responsibility and the allocation of responsibility is not so clear, considering that contracts, by their very definition transfer responsibility from the principal to the agent. This research provides a framework for exploring some of the ethical issues, including attributions of moral responsibility associated with Contract Medical Research. Using a theory of strategic and moral behavior, the research shows that both clients and sponsors in contract research have individual and collective responsibility to ensure that due care and diligence is exercised in the performance of clinical research. The research suggests some guidelines for stakeholder action.